Abstract
The role of cytokines in the pathophysiology of amyotrophic lateral sclerosis (ALS) and its relation to clinical outcome has not been clearly defined. We evaluated tumor necrosis factor-alpha (TNF-α), interferon-γ (IFN-γ) and nitric oxide (NO) levels in the serum of 22 ALS patients and 20 controls. Serum TNF-α levels and IFN-γ levels were significantly (P < 0.001) elevated in ALS patients. We also observed NO levels to be significantly (P < 0.05) increased with respect to normal subjects. We further noticed positive correlation between the duration of ALS and these proinflammatory molecule levels. Exitotoxicity and oxidative stress are known to play a crucial role in the neurodegeneration observed in ALS. Since high levels of TNF-α are known to be cytotoxic, it could be that a complex interplay of these effectors may be one of the factors underlying the progression of ALS. This study confirms the involvement of inflammation in ALS and the need to develop surrogate markers to check the progression of this disease.
Similar content being viewed by others
References
Tandan R, Bradley WG (1985) Amyotrophic lateral sclerosis: part 1. Clinical features, pathology, and ethical issues in management. Ann Neurol 18:271–280
Tandan R, Bradley WG (1985) Amyotrophic lateral sclerosis: part 2. Etiopathogenesis. Ann Neurol 18:419–431
Young AB, Penney JB, Dauth GW et al (1983) Glutamate or aspartate as a possible neurotransmitter of cerebral corticofugal fibers in the monkey. Neurology 33:1513–1516
Fonnum F (1984) Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42:1–11
O’Brien RJ, Fischbach GD (1986) Modulation of embryonic chick motoneuron glutamate sensitivity by interneurons and agonists. J Neurosci 6:3290–3296
Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623–634
Babu GN, Bawari M (1997) Single microinjection of l-glutamate induces oxidative stress in discrete regions of rat brain. Biochem Mol biol Int 43:1207–1217
Bawari M, Babu GN (2003) Metabolic responses in discrete regions of rat brain following acute administration of glutamate. Neurochem Res 28:1345–1349
Babu GN, Bawari M, Mathur VN, Kalita J, Misra UK (1998) Blood glutamate levels in patients with motor neuron disease. Clin Chim Acta 273:195–200
Silveira RC, Procianoy RS (2003) Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 143:625–629
Ergenekon E, Gucuyener K, Erbas D et al (2004) Cerebrospinal fluid and serum vascular endothelial growth factor and nitric oxide levels in newborns with hypoxic ischemic encephalopathy. Brain Dev 26:283–286
Fogal B, Hewett JA, Hewett SJ (2005) Interleukin-1beta potentiates neuronal injury in a variety of injury models involving energy deprivation. J Neuroimmunol 161:93–100
Basu A, Lazovic J, Krady JK et al (2005) Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. J Cereb Blood Flow Metab 25:17–29
Lyng K, Munkeby BH, Saugstad OD et al (2005) Effect of interleukin-10 on newborn piglet brain following hypoxia-ischemia and endotoxin-induced inflammation. Biol Neonate 87:207–216
Oygur N, Sonmez O, Saka O et al (1998) Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 79:F190–F193
Moser M, Murphy KM (2000) Dendritic cell regulation of TH1–TH2 development. Nat Immunol 1:199–205
Jensen MB, Hegelund IV, Lomholt ND et al (2000) IFN-gamma enhances microglial reactions to hippocampal axonal degeneration. J Neurosci 20:3612–3621
Pouly S, Becher B, Blain M et al (2000) Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol Exp Neurol 59:280–286
Bo L, Dawson TM, Wesselingh S et al (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36:778–786
Dawson VL, Dawson TM (1996) Nitric oxide neurotoxicity. J Chem Neuroanat 10:179–190
Lee SC, Dickson DW, Liu W et al (1993) Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol 46:19–24
Moncada S, Higgs A (1993) The l-arginine–nitric oxide pathway. N Engl J Med 329:2002–2012
Rhodes P, Leone AM, Francis PL et al (1995) The l-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 209:590–596
Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Disease/Amyotrophic lateral sclerosis of the World Federation of Neurology Research group on Neuromuscular disease and the El Escorial ‘Clinical limits of amytrophic lateral sclerosis’ workshop contributors. J Neurol Sci 124(Suppl):96–107
Norris FH, Calanchini PR, Fallat RJ et al (1974) The administration of guanidine in amyotrophic lateral sclerosis. Neurology 24:721–728
Taskiran D, Sagduyu A, Yuceyar N et al (2000) Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic lateral sclerosis. Int J Neurosci 101:65–72
Green LC, Wagner DA, Glogowski J et al (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138
Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I (2005) Estrogen and cytokines production—the possible cause of gender differences in neurological diseases. Curr Pharm Des 11(8):1017–1030
Moreau C, Devos D, Brunaud-Danel V et al (2005) Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia? Neurology 65:1958–1960
Poloni M, Facchetti D, Mai R et al (2000) Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 287:211–214
Holmoy T, Roos PM, Kvale EO (2006) ALS: cytokine profile in cerebrospinal fluid T-cell clones. Amyotroph Lateral Scler 7:183–186
Gupta RC, Milatovic D, Dettbarn WD (2002) Involvement of nitric oxide in myotoxicity produced by diisopropylphosphorofluoridate (DFP)-induced muscle hyperactivity. Arch Toxicol 76:715–726
Watanabe T, Akishita M, Toba K, Kozaki K, Eto M, Sugimoto N, Kiuchi T, Hashimotoa M, Shirakawad W, Ouchia Y (2000) Influence of sex and age on serum nitrite/nitrate concentration in healthy subjects. Clin Chim Acta 301:169–179
Salter M, Duffy C, Garthwaite J Strijbos PJ (1996) Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J Neurochem 66:1683–1690
Acknowledgment
This study was funded by a research grant awarded to G.N.B by the Council of Science and Technology, UP, India.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Babu, G.N., Kumar, A., Chandra, R. et al. Elevated Inflammatory Markers in a Group of Amyotrophic Lateral Sclerosis Patients from Northern India. Neurochem Res 33, 1145–1149 (2008). https://doi.org/10.1007/s11064-007-9564-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-007-9564-x